Our disclosure log publishes responses that we have provided under the Freedom of Information Act (FOIA). They are displayed by subject and in the order in which they were received. If you would like to make a request under the FOIA please check here first to see if the information you need has already been released.
If you have any comments or queries about the log please contact uclh.
| Title | Description | FOI Category | Date Received |
|---|---|---|---|
| Ref no FOI.2024.0385 Response | FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients | Pharmacy | 19/04/2024 |
| Ref no FOI.2024.0386 Response | FOI/2024/0386 - Stonewall funding for 2022/23-2023/24 | Finance | 19/04/2024 |
| Ref no FOI.2024.0387 Response | FOI/2024/0387 - Clinical coding episodes | Trust services | 19/04/2024 |
| Ref no FOI.2024.0377 Response | FOI/2024/0377 - ADHD assessment/ referrals and rejections | Trust services | 18/04/2024 |
| Ref no FOI.2024.0378 Response | FOI/2024/0378 - Office supplies contract | Procurement | 18/04/2024 |
| Ref no FOI.2024.0380 Response | FOI/2024/0380 - Appraisal review/ Responsible Officer/ Revalidation Officer | Human resources | 18/04/2024 |
| Ref no FOI.2024.0381 Response | FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance | Estates and facilities | 18/04/2024 |
| Ref no FOI.2024.0374 Response | FOI/2024/0374 - Energy management system/ gas and electricity contract | Estates and facilities | 17/04/2024 |
| Ref no FOI.2024.0375 Response | FOI/2024/0375 - Interview and assessment questions for HR Business Partner | Human resources | 17/04/2024 |
| Ref no FOI.2024.0376 Response | FOI/2024/0376 - Advice provided on topical medication for eczema patients | Patient treatment | 17/04/2024 |
| Ref no FOI.2024.0369 Response | FOI/2024/0369 - Autism services | Trust services | 16/04/2024 |
| Ref no FOI.2024.0370 Response | FOI/2024/0370 - Senior staff details for workforce, finance and executive board | Human resources | 16/04/2024 |
| Ref no FOI.2024.0371 Response | FOI/2024/0371 - Acute myeloid leukaemia treatment | Cancer | 16/04/2024 |
| Ref no FOI.2024.0372 Response | FOI/2024/0372 - Contact details of e-learning department | Human resources | 16/04/2024 |
| Ref no FOI.2024.0373 Response | FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service | Trust services | 16/04/2024 |
| Ref no FOI.2024.0368 Response | FOI/2024/0368 - Treatment in renal cell carcinoma | Cancer | 16/04/2024 |
| Ref no FOI.2024.0365 Response | FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes | Information technology | 15/04/2024 |
| Ref no FOI.2024.0360 Response | FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details | Procurement | 12/04/2024 |
| Ref no FOI.2024.0361 Response | FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance | Trust services | 12/04/2024 |
| Ref no FOI.2024.0362 Response | FOI/2024/0362 - Temporary staffing workforce systems and spend - 2023/24 | Information technology | 12/04/2024 |
| Ref no FOI.2024.0363 Response | FOI/2024/0363 - Freedom of Information responses available for Mesh requests | Patients | 12/04/2024 |
| Ref no FOI.2024.0355 Response | FOI/2024/0355 - Dietetics advice and guidance documents | Trust publications | 11/04/2024 |
| Ref no FOI.2024.0356 Response | FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer | Cancer | 11/04/2024 |
| Ref no FOI.2024.0357 Response | FOI/2024/0357 - Multiple myeloma treatments | Cancer | 11/04/2024 |
| Ref no FOI.2024.0354 Response | FOI/2024/0354 - Staff details for estates and facilities | Human resources | 11/04/2024 |
| Ref no FOI.2024.0352 Response | FOI/2024/0352 - Bed occupancy all sites November 2023 to March 2024 | Estates and facilities | 11/04/2024 |
| Ref no FOI.2024.0351 Response | FOI/2024/0351 - Clinical coding department services | Human resources | 10/04/2024 |
| Ref no FOI.2024.0349 Response | FOI/2024/0349 - Trust's operations and tele reporting services/ outsourced and insourced | Trust services | 10/04/2024 |
| Ref no FOI.2024.0347 Response | FOI/2024/0347 - Paediatric elective surgical waiting lists | Surgery | 10/04/2024 |
| Ref no FOI.2024.0346 Response | FOI/2024/0346 - Committee meeting management software | Information technology | 10/04/2024 |
| Ref no FOI.2024.0344 Response | FOI/2024/0344 - Cancer diagnosis following A&E attendance 2018-2023 | Cancer | 10/04/2024 |
| Ref no FOI.2024.0342 Response | FOI/2024/0342 - Single-use scopes for ENT procedures/ suppliers/ contract | Procurement | 10/04/2024 |
| Ref no FOI.2024.0341 Response | FOI/2024/0341 - Robotic Process Automation (RPA)/ Intelligent Automation (IA) technology at Trust | Information technology | 08/04/2024 |
| Ref no FOI.2024.0340 Response | FOI/2024/0340 - Medical devices/ EBME devices providers | Procurement | 08/04/2024 |
| Ref no FOI.2024.0339 Response | FOI/2024/0339 - PACS, VNA, RIS, digital pathology and cardiology PACS systems | Information technology | 08/04/2024 |
| Ref no FOI.2024.0338 Response | FOI/2024/0338 - Ophthalmology outpatient activity 2022, 2023 and 2024 | Trust services | 08/04/2024 |
| Ref no FOI.2024.0337 Response | FOI/2024/0337 - IVF clinical unit/ embryology laboratory | Women's health | 08/04/2024 |
| Ref no FOI.2024.0336 Response | FOI/2024/0336 - Special leave policy | Trust policy | 08/04/2024 |
| Ref no FOI.2024.0335 Response | FOI/2024/0335 - Cancer diagnosis by gender and age 2019/20-2023/24 | Cancer | 08/04/2024 |
| Ref no FOI.2024.0334 Response | FOI/2024/0334 - Insource and outsource provideres/ spend for pre and post covid | Finance | 05/04/2024 |
| Ref no FOI.2024.0333 Response | FOI/2024/0333 - Elective treatment wait over 65 weeks | Patients | 05/04/2024 |
| Ref no FOI.2024.0331 Response | FOI/2024/0331 - Master/ neutral vendor arrangement | Procurement | 05/04/2024 |
| Ref no FOI.2024.0330 Response | FOI/2024/0330 - Off-framework agency spend/ staff contact details | Procurement | 05/04/2024 |
| Ref no FOI.2024.0329 Response | FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification | Patients | 04/04/2024 |
| Ref no FOI.2024.0327 Response | FOI/2024/0327 - Treatment of non-UK nationals | Patients | 04/04/2024 |
| Ref no FOI.2024.0326 Response | FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease | Pharmacy | 04/04/2024 |
| Ref no FOI.2024.0325 Response | FOI/2024/0325 - Spend on settlement agreements | Finance | 04/04/2024 |
| Ref no FOI.2024.0321 Response | FOI/2024/0321 - Senior cover present in obstetric recovery | Women's health | 03/04/2024 |
| Ref no FOI.2024.0320 Response | FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases | Pharmacy | 03/04/2024 |
| Ref no FOI.2024.0319 Response | FOI/2024/0319 - Trust expenditure over £25,000 for January 2024 | Finance | 03/04/2024 |
